| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
KIF5B-RET fusions in lung adenocarcinoma.
|
Nat Med
|
2012
|
4.38
|
|
2
|
Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium.
|
J Natl Cancer Inst
|
2010
|
3.18
|
|
3
|
Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.
|
Carcinogenesis
|
2005
|
2.50
|
|
4
|
The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung.
|
Carcinogenesis
|
2009
|
1.74
|
|
5
|
Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk.
|
Carcinogenesis
|
2002
|
1.73
|
|
6
|
Expression of estrogen receptors alpha and beta in human lung tissue and cell lines.
|
Lung Cancer
|
2002
|
1.68
|
|
7
|
Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin 1 beta gene.
|
Lung Cancer
|
2005
|
1.67
|
|
8
|
Informed conditioning on clinical covariates increases power in case-control association studies.
|
PLoS Genet
|
2012
|
1.57
|
|
9
|
Genome-wide analysis of survival in early-stage non-small-cell lung cancer.
|
J Clin Oncol
|
2009
|
1.52
|
|
10
|
Association of a functional polymorphism in the promoter of the MDM2 gene with risk of nonsmall cell lung cancer.
|
Int J Cancer
|
2006
|
1.51
|
|
11
|
International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.51
|
|
12
|
Breast cancer among nurses: is the intensity of night work related to hormone receptor status?
|
Am J Epidemiol
|
2013
|
1.38
|
|
13
|
Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer.
|
Carcinogenesis
|
2003
|
1.35
|
|
14
|
The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts.
|
Clin Cancer Res
|
2011
|
1.29
|
|
15
|
CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis.
|
Carcinogenesis
|
2003
|
1.28
|
|
16
|
A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers.
|
Carcinogenesis
|
2008
|
1.27
|
|
17
|
Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis.
|
RNA Biol
|
2011
|
1.16
|
|
18
|
A combination of functional polymorphisms in the CASP8, MMP1, IL10 and SEPS1 genes affects risk of non-small cell lung cancer.
|
Lung Cancer
|
2010
|
1.13
|
|
19
|
CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls.
|
Int J Cancer
|
2003
|
1.13
|
|
20
|
International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants.
|
Carcinogenesis
|
2010
|
1.11
|
|
21
|
Sex differences in risk of lung cancer: Expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts.
|
Int J Cancer
|
2006
|
1.11
|
|
22
|
Serum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women.
|
Carcinogenesis
|
2010
|
1.07
|
|
23
|
Cigarette smoking increases copy number alterations in nonsmall-cell lung cancer.
|
Proc Natl Acad Sci U S A
|
2011
|
1.05
|
|
24
|
Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States).
|
Cancer Causes Control
|
2003
|
1.04
|
|
25
|
Genome-wide single nucleotide polymorphism analysis of lung cancer risk detects the KLF6 gene.
|
Cancer Lett
|
2007
|
1.03
|
|
26
|
DNA methylation of the CYP1A1 enhancer is associated with smoking-induced genetic alterations in human lung.
|
Int J Cancer
|
2012
|
1.02
|
|
27
|
Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer.
|
Int J Cancer
|
2004
|
1.01
|
|
28
|
A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer.
|
Carcinogenesis
|
2009
|
0.99
|
|
29
|
Night work and breast cancer risk among Norwegian nurses: assessment by different exposure metrics.
|
Am J Epidemiol
|
2011
|
0.99
|
|
30
|
Combination of protein coding and noncoding gene expression as a robust prognostic classifier in stage I lung adenocarcinoma.
|
Cancer Res
|
2013
|
0.96
|
|
31
|
Differential binding of proteins to the IL1B -31 T/C polymorphism in lung epithelial cells.
|
Cytokine
|
2007
|
0.95
|
|
32
|
Importance of CYP1A1 and CYP1B1 in bioactivation of benzo[a]pyrene in human lung cell lines.
|
Toxicol Lett
|
2009
|
0.95
|
|
33
|
Sex differences in susceptibility to PAHs is an intrinsic property of human lung adenocarcinoma cells.
|
Lung Cancer
|
2010
|
0.95
|
|
34
|
DNA methylation at promoter regions of interleukin 1B, interleukin 6, and interleukin 8 in non-small cell lung cancer.
|
Cancer Immunol Immunother
|
2012
|
0.93
|
|
35
|
Ethnic differences in frequencies of gene polymorphisms in the MYCL1 region and modulation of lung cancer patients' survival.
|
Lung Cancer
|
2006
|
0.93
|
|
36
|
Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor.
|
Eur J Cancer Prev
|
2011
|
0.92
|
|
37
|
Analysis of polymorphisms in the circadian-related genes and breast cancer risk in Norwegian nurses working night shifts.
|
Breast Cancer Res
|
2013
|
0.91
|
|
38
|
FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung.
|
Int J Cancer
|
2009
|
0.91
|
|
39
|
An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma Based on mRNA, microRNA, and DNA Methylation Biomarkers.
|
J Thorac Oncol
|
2015
|
0.90
|
|
40
|
Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.89
|
|
41
|
Association of metabolic gene polymorphisms with tobacco consumption in healthy controls.
|
Int J Cancer
|
2004
|
0.89
|
|
42
|
Polymorphisms in genes involved in xenobiotic metabolism and lung cancer risk under the age of 60 years. A pooled study of lung cancer patients in Denmark and Norway.
|
Lung Cancer
|
2004
|
0.89
|
|
43
|
Polymorphisms of dopamine receptor/transporter genes and risk of non-small cell lung cancer.
|
Lung Cancer
|
2006
|
0.88
|
|
44
|
Quantitative analysis of benzo[a]pyrene biotransformation and adduct formation in Ahr knockout mice.
|
Toxicol Lett
|
2006
|
0.87
|
|
45
|
CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.
|
Int J Cancer
|
2013
|
0.86
|
|
46
|
Impact on disease development, genomic location and biological function of copy number alterations in non-small cell lung cancer.
|
PLoS One
|
2011
|
0.85
|
|
47
|
Functional effect of polymorphisms in 15q25 locus on CHRNA5 mRNA, bulky DNA adducts and TP53 mutations.
|
Int J Cancer
|
2012
|
0.84
|
|
48
|
Role of estrogen receptor in regulation of polycyclic aromatic hydrocarbon metabolic activation in lung.
|
Lung Cancer
|
2004
|
0.84
|
|
49
|
Natural and orthogonal interaction framework for modeling gene-environment interactions with application to lung cancer.
|
Hum Hered
|
2012
|
0.82
|
|
50
|
Common polymorphisms in D12S1034 flanking genes RASSF8 and BHLHB3 are not associated with lung adenocarcinoma risk.
|
Lung Cancer
|
2006
|
0.81
|
|
51
|
Functional analysis of a lung cancer risk haplotype in the IL1B gene regulatory region.
|
J Hum Genet
|
2012
|
0.80
|
|
52
|
Msh2 deficiency increases susceptibility to benzo[a]pyrene-induced lymphomagenesis.
|
Int J Cancer
|
2006
|
0.78
|
|
53
|
Allele-specific induction of IL1B -31T/C promoter polymorphism by lung carcinogens.
|
Mutat Res
|
2008
|
0.78
|
|
54
|
Biotransformation of formaldehyde in cultured human bronchus.
|
Environ Res
|
2002
|
0.75
|